Oxadiazole derivatives and their medical use
This invention relates to novel oxadiazole derivatives, which are found to be modulators of the nicotinic acetylcholine receptors. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.
1. An oxadiazole derivative, which is
3-(3-Pyridin-3-yl-[1,2,4]oxadiazol-5-yl)-benzonitrile,
or a pharmaceutically-acceptable addition salt thereof.
2. A pharmaceutical composition comprising a therapeutically effective amount of the oxadiazole derivative of claim 1 , or a pharmaceutically-acceptable addition salt thereof, together with at least one pharmaceutically-acceptable carrier or diluent.